Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feuerstein

Showing results (241-250 of 2,146) with videos related to

Pageof 215
Sort By:
Pathologie-Biologie|September 1, 1995
[Degeneration of catecholaminergic neurons]C Chatellard-Causse, C Feuerstein
Current Urology Reports|September 7, 2015
Quality of Life Outcomes for Bladder Cancer Patients Undergoing Bladder Preservation with RadiotherapyMichael A Feuerstein, Anuj Goenka
European Journal of Cancer Care|August 16, 2017
Cancer, comorbidity and workplace discrimination: The US experienceAmanda K Gehrke, Michael Feuerstein
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1987
Identification of a prominent nuclear protein associated with proliferation of normal and malignant B cellsN Feuerstein, J J Mond
Biochimica Et Biophysica Acta|April 5, 1984
Studies of the differentiation of promyelocytic cells by phorbol ester. I. Induction of discrete membrane proteins characteristic of monocytes and expression of motility functions in HL-60 cells following differentiation by phorbol esterN Feuerstein, H L Cooper
Journal of Neurotrauma|October 1, 1995
Induced expression of adhesion molecules following focal brain ischemiaX Wang, G Z Feuerstein
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 25, 1999
Mathematical analysis of the control of neurotransmitter release by presynaptic receptors as a supplement to experimental dataT J Feuerstein, N Limberger
Pain|August 1, 1989
Fear, alexithymia and cancer painJ A Dalton, M Feuerstein
Drug News & Perspectives|August 26, 2003
Role of immune and inflammatory mediators in CNS injuryX Wang, G Z Feuerstein
Current Pharmaceutical Design|October 8, 2003
Enzyme and proton-activated prodrugs for a selective cancer therapyL F Tietze, T Feuerstein
Pageof 215

Showing results (241-250 of 2,146) with videos related to

Sort By:
Pageof 215
Pathologie-Biologie|September 1, 1995
[Degeneration of catecholaminergic neurons]C Chatellard-Causse, C Feuerstein
Current Urology Reports|September 7, 2015
Quality of Life Outcomes for Bladder Cancer Patients Undergoing Bladder Preservation with RadiotherapyMichael A Feuerstein, Anuj Goenka
European Journal of Cancer Care|August 16, 2017
Cancer, comorbidity and workplace discrimination: The US experienceAmanda K Gehrke, Michael Feuerstein
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1987
Identification of a prominent nuclear protein associated with proliferation of normal and malignant B cellsN Feuerstein, J J Mond
Biochimica Et Biophysica Acta|April 5, 1984
Studies of the differentiation of promyelocytic cells by phorbol ester. I. Induction of discrete membrane proteins characteristic of monocytes and expression of motility functions in HL-60 cells following differentiation by phorbol esterN Feuerstein, H L Cooper
Journal of Neurotrauma|October 1, 1995
Induced expression of adhesion molecules following focal brain ischemiaX Wang, G Z Feuerstein
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 25, 1999
Mathematical analysis of the control of neurotransmitter release by presynaptic receptors as a supplement to experimental dataT J Feuerstein, N Limberger
Pain|August 1, 1989
Fear, alexithymia and cancer painJ A Dalton, M Feuerstein
Drug News & Perspectives|August 26, 2003
Role of immune and inflammatory mediators in CNS injuryX Wang, G Z Feuerstein
Current Pharmaceutical Design|October 8, 2003
Enzyme and proton-activated prodrugs for a selective cancer therapyL F Tietze, T Feuerstein
Pageof 215